The Centre for Probe Development and Commercialization (CPDC) is a leader in radiopharmaceutical research and development, founded in 2008. It specializes in the discovery, development, and clinical translation of diagnostic and therapeutic radiopharmaceuticals across Canada. CPDC has been integral to the growth of the radiopharmaceutical ecosystem, successfully incubating and spinning out companies like Fusion Pharmaceuticals and Atom Vie. With over 65,000 clinical doses provided to patients, CPDC supports more than 25 clinical trials in Canada, North America, and Europe, focusing on innovative imaging agents and targeted radiotherapeutics for various diseases.
Something looks off?